Search Results
Apr 02, 2026, 09:00 ET BillionToOne Appoints Dr. Allen Chen as Vice President of Medical Affairs and Clinical Development, Oncology
translational research development for BillionToOne's Northstar oncology portfolio. Northstar Select® is an ultra-sensitive, 84-gene, single-molecule NGS-based ctDNA panel designed to identify actionable genomic alterations in patients with advanced solid tumors, giving oncologists a comprehensive liquid
More news about: BillionToOne
Apr 02, 2026, 08:15 ET CellCarta and Pillar Biosciences Announce Multi-Year Global Strategic Partnership to Expand Rapid, Decentralized Tumor Profiling for Oncology Clinical Trials
for drug development, and Pillar Biosciences, a leader in NGS-based oncology molecular diagnostics, today announced a global multi-year strategic partnership to broaden access to fast, operationally streamlined next-generation sequencing (NGS) tumor profiling for biopharma sponsors and clinical research
More news about: CellCarta
Mar 31, 2026, 07:56 ET n6 Appoints Broad Institute Principal Investigator Aziz Al'Khafaji as Scientific Advisor, Advancing AutoNorm™ as the New Standard in NGS Library Preparation
economic and scientific gains."Dr. Pranav Patel, CEO, n6n6's icon96 platform simultaneously amplifies, quantifies, and normalizes NGS libraries — with AutoNorm monitoring fluorescence in real time and terminating each well independently at its optimal cycle endpoint. The result is sequencing-ready,
More news about: n6
Mar 29, 2026, 08:57 ET n6 Launches icon16™, Expanding AutoNorm™ Adaptive Amplification to Lower-Throughput NGS Workflows
and major NGS platforms.Building on that momentum, n6 is bringing the same standard of adaptive amplification to more laboratories with the launch of icon16™.icon16 is not a stripped-down instrument. It is AutoNorm in a 16-well format, purpose-built for labs running NGS at lower throughput,
More news about: n6
Mar 27, 2026, 10:01 ET Human Identification Market worth $1.69 billion by 2031 | MarketsandMarkets™
By product, the consumables segment is projected to grow at the highest CAGR of 11.3% between 2026 and 2031.By technology, the NGS segment is expected to grow at the highest CAGR of 12.4% over the forecast period.The Asia Pacific is the fastest-growing regional segment at
More news about: MarketsandMarkets
Mar 25, 2026, 10:45 ET Veterinary Diagnostics Market Size Worth USD 19.63 Billion by 2032, Exclusive Report by Maximize Market Research
Veterinary Molecular Diagnostics Market by Product (Kits & Reagents, Instruments), Technology (PCR, NGS, Immunoassays), Application (Companion Animals, Livestock, Poultry) and Region – Global Forecast to 2032
More news about: Maximize Market Research Pvt. Ltd.
Mar 25, 2026, 03:33 ET Global Artificial Intelligence (AI) in Precision Medicine Market to Attain USD 10.32 Billion by 2032, Witnessing a CAGR of 31.35%, Says MarkNtel Advisors
this momentum, in 2025, Illumina and Tempus AI announced a strategic collaboration to accelerate the clinical adoption of next-generation sequencing (NGS) technologies. By combining Illumina's advanced AI capabilities with Tempus's multimodal data platform, the partnership focuses on developing and training
More news about: MarkNtel Advisors
Mar 24, 2026, 10:15 ET Digital Dentistry Market to Reach US$ 13.7 Billion by 2033 Expands Amid Rapid Technological Adoption and Precision Care Demand - Persistence Market Research
(Oncology, Infectious Diseases, Genetic & Hereditary Disorders, Transplant Monitoring, Pharmacogenomics, Prenatal & Reproductive Health, Technology (NGS, PCR-based Technologies, Microarrays, Nanopore Sequencing, Bioinformatics Platforms), End-User (Hospitals & Clinics, Diagnostic & Reference Laboratories,
More news about: Persistence Market Research Pvt. Ltd.
Mar 24, 2026, 08:30 ET ePlus Named To Prestigious CRN Tech Elite 250 For 2026
HERNDON, Va., March 24, 2026 /PRNewswire/ -- ePlus inc. (NASDAQ NGS: PLUS) (news) today announced that it has once
More news about: EPLUS INC.
Mar 23, 2026, 16:59 ET Rapid Food Testing Market to Attain USD 29.43 Billion by 2032, Driven by Rising Food Safety Concerns, Reports MarkNtel Advisors
The growing adoption of PCR (Polymerase Chain Reaction), immunoassays (ELISA), chromatography techniques, biosensors, and next-generation sequencing (NGS) is enabling highly accurate and time-efficient detection of contaminants.Additionally, the emergence of lab-on-chip platforms and portable diagnostic
More news about: MarkNtel Advisors
Mar 19, 2026, 22:29 ET Basecamp Research lança Trillion Gene Atlas para ampliar terapias desenvolvidas por IA
industrial, incluindo leituras longas ricas em dados e de alta precisão.A Ultima é uma desenvolvedora de sistemas de sequenciamento de próxima geração (NGS) de rendimento ultra-alto. O mais recente sistema de sequenciamento da Ultima, a Série UG200, avança a arquitetura exclusiva de sequenciamento baseada
More news about: Basecamp Research
Mar 19, 2026, 22:26 ET Basecamp Research presenta Trillion Gene Atlas para escalar la terapia diseñada por IA
industrial, incluidas lecturas largas ricas en datos y de alta precisión.Ultima es un desarrollador de sistemas de secuenciación de próxima generación (NGS) de ultra alto rendimiento. El último sistema de secuenciación de Ultima, la serie UG200, avanza en la arquitectura de secuenciación basada en obleas
More news about: Basecamp Research
Mar 19, 2026, 22:04 ET Basecamp Research 推出 Trillion Gene Atlas（萬億基因組圖譜）以規模化人工智能設計療法
(ultra-high-throughput short- and long-read) 測序以及加速運算的進步。 Basecamp 已與 Ultima Genomics 和 PacBio 合作，提供工業規模的測序服務，包括數據豐富且極度準確的長讀長測序。Ultima 是超高通量新一代測序 (NGS) 系統的開發商。 Ultima 最新推出的 UG200 系列測序系統，在其獨特的晶圓級測序架構上再作突破，能以極具競爭力的成本，實現工業級規模的高通量全基因組及多組學測序，以支持類似 Trillion Gene Atlas 的計劃。Ultima Genomics 創辦人兼行政總裁 Gilad
More news about: Basecamp Research
Mar 19, 2026, 10:01 ET Preimplantation Genetic Testing Market to Reach US$ 1,081.9 Million by 2033 Amid Rising IVF Adoption and Technological Innovation - Persistence Market Research
next-generation sequencing (NGS) and AI-assisted embryo assessment, are transforming the PGT market. NGS offers comprehensive chromosome screening, boosting clinical pregnancy rates from 45.6% to 54.4% and live birth
More news about: Persistence Market Research Pvt. Ltd.
Mar 19, 2026, 08:17 ET CellCarta Secures Global Exclusivity for Biofidelity's Aspyre® Lung to Advance Targeted Lung Cancer Testing
guide patient enrollment and treatment decisions. Broad next-generation sequencing (NGS) panels are frequently used for this purpose, but they can take three weeks or more to complete, and 25% of lung cancer samples fail NGS testing. Additionally, the costs can be high compared to other modalities. As a
More news about: CellCarta
Mar 18, 2026, 21:44 ET Basecamp Research startet den Trillion Gene Atlas, um KI-entwickelte Therapeutika zu skalieren
bereitzustellen, darunter datenreiche Long Reads mit hoher Genauigkeit.Ultima entwickelt Ultra-High-Throughput-Systeme für Next-Generation-Sequencing (NGS). Das jüngste Sequenzierungssystem von Ultima, die UG200 Series, entwickelt die einzigartige waferbasierte Sequenzierungsarchitektur des Unternehmens
More news about: Basecamp Research
Mar 18, 2026, 18:01 ET Basecamp Research lance le Trillion Gene Atlas pour développer des thérapies conçues par l'IA
des lectures longues riches en données et d'une grande précision.Ultima est un développeur de systèmes de séquençage de nouvelle génération (NGS) à très haut rendement. Le dernier système de séquençage d'Ultima, la série UG200, fait progresser l'architecture de séquençage unique de l'entreprise,
More news about: Basecamp Research
Mar 18, 2026, 12:18 ET Basecamp Research lanza el Atlas de un billón de genes para impulsar terapias diseñadas con IA
incluyendo lecturas largas de alta precisión y gran cantidad de datos.Ultima es desarrollador de sistemas de secuenciación de próxima generación (NGS) de ultra alto rendimiento. El último sistema de secuenciación de Ultima, la serie UG200, perfecciona la arquitectura de secuenciación basada en obleas
More news about: Basecamp Research
Mar 18, 2026, 09:15 ET Illumina and Labcorp expand collaboration to broaden access to precision oncology testing
laboratory services, today announced an expanded collaboration to advance precision oncology through innovative applications of next-generation sequencing (NGS) solutions across the healthcare ecosystem. Projects are expected to include promoting equitable access to cancer biomarker testing by bringing it closer
More news about: Illumina, Inc.
Mar 18, 2026, 09:00 ET Collision Engineering Career Alliance Awarded U.S. Department of Labor National Apprenticeship Guidelines
education and industry to transform how collision repair technicians are trained and retained. The National Guidelines for Apprenticeship Standards (NGS) certification is a model for developing local programs that meet all regulatory requirements under federal law with the Office of Apprenticeship."The
More news about: Collision Engineering Career Alliance
Mar 18, 2026, 05:00 ET Basecamp Research Launches Trillion Gene Atlas to Scale AI-Designed Therapeutics
industrial-scale sequencing including data-rich, high-accuracy long reads.Ultima is a developer of ultra-high throughput next- generation sequencing (NGS) systems. Ultima's latest sequencing system, the UG200 Series, advances the company's unique wafer-based sequencing architecture to enable high-throughput,
More news about: Basecamp Research
Mar 18, 2026, 05:00 ET Basecamp Research Launches Trillion Gene Atlas to Scale AI-Designed Therapeutics
industrial-scale sequencing including data-rich, high-accuracy long reads.Ultima is a developer of ultra-high throughput next- generation sequencing (NGS) systems. Ultima's latest sequencing system, the UG200 Series, advances the company's unique wafer-based sequencing architecture to enable high-throughput,
More news about: Basecamp Research
Mar 18, 2026, 01:23 ET Golden Helix geht eine Partnerschaft mit den Austrian Human Genetics Labs ein, um Fortschritte in der Genommedizin voranzutreiben
18. März 2026 /PRNewswire/ -- Golden Helix, ein weltweit führender Anbieter von Bioinformatik-Lösungen für Next-Generation-Sequencing (NGS) und Präzisionsmedizin, gibt stolz eine strategische Vereinbarung mit den öffentlichen medizinischen Genetiklabors in Österreich bekannt. Die Vereinbarung
More news about: Golden Helix, Inc.
Mar 17, 2026, 08:00 ET Golden Helix Partners with the Austrian Human Genetics Labs to Drive Advancements in Genomic Medicine
March 17, 2026 /PRNewswire/ -- Golden Helix, a global leader in bioinformatics solutions for Next-Generation Sequencing (NGS) and precision medicine, is proud to announce a strategic agreement with the Austrian public medical genetics labs. The agreement aims to enhance the
More news about: Golden Helix, Inc.
Mar 17, 2026, 08:00 ET Golden Helix Partners with the Austrian Human Genetics Labs to Drive Advancements in Genomic Medicine
March 17, 2026 /PRNewswire/ -- Golden Helix, a global leader in bioinformatics solutions for Next-Generation Sequencing (NGS) and precision medicine, is proud to announce a strategic agreement with the Austrian public medical genetics labs. The agreement aims to enhance the
More news about: Golden Helix, Inc.